Use of subcutaneous thymopentin in the treatment of steroid-dependent relapsing minimal-change nephrotic syndrome.
Cheng
I K
IK
Jones
B M
BM
D000328:Adult; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D009402:Nephrosis, Lipoid / Q000188:drug therapy* / Q000276:immunology; D012008:Recurrence; D013256:Steroids / Q000627:therapeutic use; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D016305:Thymopentin / Q000008:administration & dosage*
D013256:Steroids; D016305:Thymopentin